Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangxue Shengfa Capsules is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Tianjin Hongrentang Pharmaceutical. It is primarily indicated for the treatment of hair loss (alopecia) and the promotion of hair growth. According to TCM theory, the capsules work by nourishing the blood, tonifying the liver and kidney, and dispelling wind to address the underlying causes of hair thinning and loss. The formulation typically consists of several herbal ingredients, including *Rehmannia glutinosa*, *Angelica sinensis*, *Polygonum multiflorum* (He Shou Wu), and *Notopterygium incisum*. It is administered orally and has received regulatory approval in China for conditions such as alopecia areata and seborrheic alopecia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangxue Shengfa Capsules.